One small study of patients with early, untreated Parkinsons disease given high dose intravenous glutathione twice a day for 30 days showed symptom improvement that lasted for 2-4 months after treatment ended (17)
If you have specific metabolic concerns, discuss them with your provider in the context of those conditions rather than weight loss
If you're losing muscle rather than fat, you may be trading short-term weight loss for long-term metabolic damage
Similar content being viewed by others Introduction Glucagon-like peptide 1 receptor agonist (GLP-1 RA) therapies have demonstrated efficacy and safety in patients with type 2 diabetes (T2D) and in people with obesity [1,2,3,4,5]
Recent studies suggest that combining NAMPT inhibitors with other therapies could enhance their efficacy and reduce resistance in cancer treatment, as shown in various preclinical animal models 217,218
In fact, the U.S